Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics group.
暂无分享,去创建一个
C. Gordon | D. Isenberg | K. Kalunian | M. Petri | V. Farewell | J. Merrill | S. Wollaston
[1] D. Gladman,et al. The Systemic Lupus International Collaborating Clinics Group - origins and outcomes , 2001, Lupus.
[2] D. Isenberg,et al. Assessing patients with lupus: towards a drug responder index. , 1999, Rheumatology.
[3] P. Tugwell,et al. Outcome measures to be used in clinical trials in systemic lupus erythematosus. , 1999, The Journal of rheumatology.
[4] D. Isenberg,et al. Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus. , 1996, Annals of the rheumatic diseases.
[5] C. Bombardier,et al. Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. , 1994, The Journal of rheumatology.
[6] D A Isenberg,et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. , 1993, The Quarterly journal of medicine.
[7] S. Gabriel,et al. A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus. , 1993, The Journal of rheumatology.